Posted at 09:40h
in
Uncategorized
Vaccibody enters into worldwide license agreement with Adaptive Biotechnologies for clinically validated SARS-CoV-2 T cell epitopes
View press release (PDF)...
Posted at 08:34h
in
Uncategorized
Vaccibody to initiate a phase 1/2 trial to evaluate two second-generation SARS CoV-2 virus DNA vaccine candidates
View press release (PDF)...
Posted at 08:00h
in
Uncategorized
Vaccibody to present at Goldman Sachs 42nd Annual Global Healthcare Conference
View press release (PDF)...
Posted at 09:14h
in
Uncategorized
Vaccibody to present at Jefferies Virtual Healthcare Conference (June 1-4, 2021)
View announcement (PDF)...
Posted at 08:47h
in
Uncategorized
Vaccibody appoints Mikkel Wandahl Pedersen as new Chief Scientific Officer and Agnete B. Fredriksen as Chief Innovation & Strategy Officer...
Posted at 16:18h
in
Uncategorized
View press release (PDF)...
Posted at 14:39h
in
Uncategorized
View press release (PDF)
MINUTES OF ANNUAL GENERAL MEETING IN VACCIBODY AS (PDF)...
Posted at 08:26h
in
Uncategorized
Status update on VB C-02 clinical trial...
Posted at 08:08h
in
Uncategorized
Vaccibody appoints Harald Gurvin as new Chief Financial Officer
View press release (PDF)...
Posted at 08:02h
in
Uncategorized
Notice of AGM on May 5, 2021
View press release (PDF)...
